{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:17:42Z","timestamp":1784333862392,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>SOX11 overexpression has been associated with aggressive behavior of mantle cell lymphomas (MCL). SOX11 is overexpressed in embryonic and cancer stem cells (CSC) of some tumors. Although CSC have been isolated from primary MCL, their relationship to SOX11 expression and contribution to MCL pathogenesis and clinical evolution remain unknown. Here, we observed enrichment in leukemic and hematopoietic stem cells gene signatures in SOX11+ compared to SOX11\u2013 MCL primary cases. Musashi-2 (MSI2) emerged as one of the most significant upregulated stem cell-related genes in SOX11+ MCLs. SOX11 is directly bound to the <jats:italic>MSI2<\/jats:italic> promoter upregulating its expression in vitro. <jats:italic>MSI2<\/jats:italic> intronic enhancers were strongly activated in SOX11+ MCL cell lines and primary cases. MSI2 upregulation was significantly associated with poor overall survival independently of other high-risk features of MCL. MSI2 knockdown decreased the expression of genes related to apoptosis and stem cell features and significantly reduced clonogenic growth, tumor cell survival and chemoresistance in MCL cells. MSI2-knockdown cells had reduced tumorigenic engraftment into mice bone marrow and spleen compared to control cells in xenotransplanted mouse models. Our results suggest that MSI2 might play a key role in sustaining stemness and tumor cell survival, representing a possible novel target for therapeutic interventions in MCL.<\/jats:p>","DOI":"10.1038\/s41375-022-01776-x","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T11:03:05Z","timestamp":1670842985000},"page":"408-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma"],"prefix":"10.1038","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8931-2673","authenticated-orcid":false,"given":"Marta","family":"Sureda-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Balsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta-Leonor","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2910-9440","authenticated-orcid":false,"given":"Ferran","family":"Nadeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"De Bol\u00f2s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Eguileor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8104-9620","authenticated-orcid":false,"given":"Marta","family":"Kulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gin\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Demajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8401-579X","authenticated-orcid":false,"given":"Pedro","family":"Jares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-5195","authenticated-orcid":false,"given":"Jos\u00e9 I.","family":"Mart\u00edn-Subero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Be\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9850-9793","authenticated-orcid":false,"given":"Elias","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3016-2874","authenticated-orcid":false,"given":"Virginia","family":"Amador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"1776_CR1","doi-asserted-by":"publisher","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 2017 https:\/\/doi.org\/10.1017\/CBO9781107415324.004.","DOI":"10.1017\/CBO9781107415324.004"},{"key":"1776_CR2","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","volume":"70","author":"V Fern\u00e0ndez","year":"2010","unstructured":"Fern\u00e0ndez V, Salamero O, Espinet B, Sol\u00e9 F, Royo C, Navarro A, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010;70:1408\u201318.","journal-title":"Cancer Res"},{"key":"1776_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.hoc.2020.05.002","volume":"34","author":"A Navarro","year":"2020","unstructured":"Navarro A, Be\u00e0 S, Jares P, Campo E. Molecular pathogenesis of mantle cell lymphoma. Hematol Oncol Clin North Am. 2020;34:795\u2013807.","journal-title":"Hematol Oncol Clin North Am"},{"key":"1776_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/MOH.0000000000000434","volume":"25","author":"R Beekman","year":"2018","unstructured":"Beekman R, Amador V, Campo E. SOX11, a key oncogenic factor in mantle cell lymphoma. Curr Opin Hematol. 2018;25:299\u2013306.","journal-title":"Curr Opin Hematol"},{"key":"1776_CR5","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","volume":"72","author":"A Navarro","year":"2012","unstructured":"Navarro A, Clot G, Royo C, Jares P, Hadzidimitriou A, Agathangelidis A, et al. Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. Cancer Res. 2012;72:5307\u201316.","journal-title":"Cancer Res"},{"key":"1776_CR6","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1172\/JCI61272","volume":"122","author":"P Jares","year":"2012","unstructured":"Jares P, Colomer D, Campo E. Molecular pathogenesis of mantle cell lymphoma. J Clin Invest. 2012;122:3416\u201323.","journal-title":"J Clin Invest"},{"key":"1776_CR7","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.ccell.2016.09.014","volume":"30","author":"AC Queir\u00f3s","year":"2016","unstructured":"Queir\u00f3s AC, Beekman R, Vilarrasa-Blasi R, Duran-Ferrer M, Clot G, Merkel A, et al. Decoding the DNA methylome of mantle cell lymphoma in the light of the entire B cell lineage. Cancer Cell. 2016;30:806\u201321.","journal-title":"Cancer Cell"},{"key":"1776_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/PAS.0b013e3182a43996","volume":"38","author":"D Soldini","year":"2014","unstructured":"Soldini D, Valera A, Sol\u00e9 C, Palomero J, Amador V, Martin-Subero JI, et al. Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma. Am J Surg Pathol. 2014;38:86\u201393.","journal-title":"Am J Surg Pathol"},{"key":"1776_CR9","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1182\/blood-2012-06-438937","volume":"121","author":"MC Vegliante","year":"2013","unstructured":"Vegliante MC, Palomero J, P\u00e9rez-Gal\u00e1n P, Rou\u00e9 G, Castellano G, Navarro A, et al. SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma. Blood. 2013;121:2175\u201385.","journal-title":"Blood"},{"key":"1776_CR10","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/leu.2015.355","volume":"30","author":"J Palomero","year":"2016","unstructured":"Palomero J, Vegliante MC, Eguileor A, Rodr\u2019guez ML, Balsas P, Mart\u2019nez D, et al. SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6. Leukemia. 2016;30:1580\u201399.","journal-title":"Leukemia"},{"key":"1776_CR11","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1182\/blood-2018-02-832535","volume":"131","author":"PY Kuo","year":"2018","unstructured":"Kuo PY, Jatiani SS, Rahman AH, Edwards D, Jiang Z, Ahr K, et al. SOX11 augments BCR signaling to drive MCL-like tumor development. Blood. 2018;131:2247\u201355.","journal-title":"Blood"},{"key":"1776_CR12","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1182\/blood-2014-04-569566","volume":"124","author":"J Palomero","year":"2014","unstructured":"Palomero J, Vegliante MC, Rodr\u00edguez ML, Eguileor \u00c1, Castellano G, Planas-Rigol E, et al. SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma. Blood. 2014;124:2235\u201347.","journal-title":"Blood"},{"key":"1776_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1182\/blood-2017-04-776740","volume":"130","author":"P Balsas","year":"2017","unstructured":"Balsas P, Palomero J, Eguileor \u00c1, Rodr\u00edguez ML, Vegliante MC, Planas-Rigol E, et al. SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma. Blood. 2017;130:501\u201313.","journal-title":"Blood"},{"key":"1776_CR14","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1182\/blood.2020010527","volume":"138","author":"P Balsas","year":"2021","unstructured":"Balsas P, Veloza L, Clot G, Sureda-G\u00f3mez M, Rodriguez M-L, Masaoutis C, et al. SOX11, CD70 and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma. Blood. 2021;138:2202\u201315.","journal-title":"Blood"},{"key":"1776_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-020-00451-w","volume":"6","author":"HM Zhou","year":"2021","unstructured":"Zhou HM, Zhang JG, Zhang X, Li Q. Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents. Signal Transduct Target Ther. 2021;6:1\u201317.","journal-title":"Signal Transduct Target Ther"},{"key":"1776_CR16","doi-asserted-by":"publisher","unstructured":"Medina DJ, Abass-Shereef J, Walton K, Goodell L, Aviv H, Strair RK, et al. Cobblestone-area forming cells derived from patients with mantle cell lymphoma are enriched for CD133+ tumor-initiating cells. PLoS One. 2014;9:e91042. https:\/\/doi.org\/10.1371\/journal.pone.0091042.","DOI":"10.1371\/journal.pone.0091042"},{"key":"1776_CR17","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3109\/10428194.2011.562570","volume":"52","author":"HJ Jung","year":"2011","unstructured":"Jung HJ, Chen Z, McCarty N. Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma. Leuk Lymphoma. 2011;52:1066\u201379.","journal-title":"Leuk Lymphoma"},{"key":"1776_CR18","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.3109\/10428194.2015.1025391","volume":"56","author":"SM Kim","year":"2015","unstructured":"Kim SM, Lee ST, Ryu KJ, Kim HJ, Kim SH, Ko YH, et al. A subset of CD45+\/CD19-cells in bone marrow may be associated with clinical outcomes of patients with mantle cell lymphoma. Leuk Lymphoma. 2015;56:3052\u20137.","journal-title":"Leuk Lymphoma"},{"key":"1776_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.scr.2010.07.003","volume":"5","author":"Z Chen","year":"2010","unstructured":"Chen Z, Ayala P, Wang M, Fayad L, Katz RL, Romaguera J, et al. Prospective isolation of clonogenic mantle cell lymphoma-initiating cells. Stem Cell Res. 2010;5:212\u201325.","journal-title":"Stem Cell Res"},{"key":"1776_CR20","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1038\/onc.2013.177","volume":"33","author":"K Teshima","year":"2014","unstructured":"Teshima K, Nara M, Watanabe A, Ito M, Ikeda S, Hatano Y, et al. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma. Oncogene. 2014;33:2191\u2013203.","journal-title":"Oncogene"},{"key":"1776_CR21","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/j.1582-4934.2009.00865.x","volume":"14","author":"F Vega","year":"2010","unstructured":"Vega F, Davuluri Y, Cho-Vega JH, Singh RR, Ma S, Wang RY, et al. Side population of a murine mantle cell lymphoma model contains tumour-initiating cells responsible for lymphoma maintenance and dissemination. J Cell Mol Med. 2010;14:1532\u201345.","journal-title":"J Cell Mol Med"},{"key":"1776_CR22","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1182\/blood-2010-02-268375","volume":"116","author":"SK Brennan","year":"2010","unstructured":"Brennan SK, Meade B, Wang Q, Merchant AA, Kowalski J, Matsui W. Mantle cell lymphoma activation enhances bortezomib sensitivity. Blood. 2010;116:4185\u201391.","journal-title":"Blood"},{"key":"1776_CR23","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1517\/14656560902895715","volume":"10","author":"M Prichard","year":"2009","unstructured":"Prichard M, Harris T, Williams ME, Densmore JJ. Treatment strategies for relapsed and refractory aggressive non-Hodgkin\u2019s lymphoma. Expert Opin Pharmacother. 2009;10:983\u201395.","journal-title":"Expert Opin Pharmacother"},{"key":"1776_CR24","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1242\/dev.091793","volume":"140","author":"Y Kamachi","year":"2013","unstructured":"Kamachi Y, Kondoh H. Sox proteins: regulators of cell fate specification and differentiation. Development. 2013;140:4129\u201344.","journal-title":"Development"},{"key":"1776_CR25","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1089\/scd.2014.0297","volume":"23","author":"EM Abdelalim","year":"2014","unstructured":"Abdelalim EM, Emara MM, Kolatkar PR. The SOX transcription factors as key players in pluripotent stem cells. Stem Cells Dev. 2014;23:2687\u201399.","journal-title":"Stem Cells Dev"},{"key":"1776_CR26","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell"},{"key":"1776_CR27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-020-2195-y","volume":"580","author":"SO Dodonova","year":"2020","unstructured":"Dodonova SO, Zhu F, Dienemann C, Taipale J, Cramer P. Nucleosome-bound SOX2 and SOX11 structures elucidate pioneer factor function. Nature. 2020;580:669\u201372.","journal-title":"Nature"},{"key":"1776_CR28","doi-asserted-by":"publisher","first-page":"654031","DOI":"10.3389\/fnmol.2021.654031","volume":"14","author":"M Stevanovic","year":"2021","unstructured":"Stevanovic M, Drakulic D, Lazic A, Ninkovic DS, Schwirtlich M, Mojsin M. SOX transcription factors as important regulators of neuronal and glial differentiation during nervous system development and adult neurogenesis. Front Mol Neurosci. 2021;14:654031.","journal-title":"Front Mol Neurosci"},{"key":"1776_CR29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature20123","volume":"539","author":"I Tirosh","year":"2016","unstructured":"Tirosh I, Venteicher AS, Hebert C, Escalante LE, Patel AP, Yizhak K, et al. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature. 2016;539:309\u201313.","journal-title":"Nature"},{"key":"1776_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/path.4939","volume":"243","author":"E Oliemuller","year":"2017","unstructured":"Oliemuller E, Kogata N, Bland P, Kriplani D, Daley F, Haider S, et al. SOX11 promotes invasive growth and ductal carcinoma in situ progression. J Pathol. 2017;243:193\u2013207.","journal-title":"J Pathol"},{"key":"1776_CR31","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3324\/haematol.2016.160374","volume":"102","author":"A Navarro","year":"2017","unstructured":"Navarro A, Clot G, Mart\u00ednez-Trillos A, Pinyol M, Jares P, Gonz\u00e1lez-Farr\u00e9 B, et al. Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier. Haematologica. 2017;102:360\u20133.","journal-title":"Haematologica"},{"key":"1776_CR32","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1182\/blood.2020005289","volume":"136","author":"F Nadeu","year":"2020","unstructured":"Nadeu F, Martin-Garcia D, Clot G, D\u00edaz-Navarro A, Duran-Ferrer M, Navarro A, et al. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes. Blood. 2020;136:1419\u201332.","journal-title":"Blood"},{"key":"1776_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-20849-y","volume":"12","author":"R Vilarrasa-Blasi","year":"2021","unstructured":"Vilarrasa-Blasi R, Soler-Vila P, Verdaguer-Dot N, Russi\u00f1ol N, Di Stefano M, Chapaprieta V, et al. Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation. Nat Commun. 2021;12:1\u201318.","journal-title":"Nat Commun"},{"key":"1776_CR34","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41591-018-0028-4","volume":"24","author":"R Beekman","year":"2018","unstructured":"Beekman R, Chapaprieta V, Russi\u00f1ol N, Vilarrasa-Blasi R, Verdaguer-Dot N, Martens JHA, et al. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia. Nat Med. 2018;24:868.","journal-title":"Nat Med"},{"key":"1776_CR35","doi-asserted-by":"publisher","unstructured":"Minuesa G, Albanese SK, Xie W, Kazansky Y, Worroll D, Chow A, et al. Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia. Nat Commun. 2019;10:2691. https:\/\/doi.org\/10.1038\/s41467-019-10523-3.","DOI":"10.1038\/s41467-019-10523-3"},{"key":"1776_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1182\/blood-2014-06-584417","volume":"125","author":"R Scheicher","year":"2015","unstructured":"Scheicher R, Hoelbl-Kovacic A, Bellutti F, Tigan A-S, Prchal-Murphy M, Heller G, et al. CDK6 as a key regulator of hematopoietic and leukemic stem cell activation. Blood. 2015;125:90\u2013101.","journal-title":"Blood"},{"key":"1776_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2050-7771-1-23","volume":"1","author":"N Liu","year":"2013","unstructured":"Liu N, Zhang J, Ji C. The emerging roles of Notch signaling in leukemia and stem cells. Biomark Res. 2013;1:1\u20137.","journal-title":"Biomark Res"},{"key":"1776_CR38","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nature09171","volume":"466","author":"T Ito","year":"2010","unstructured":"Ito T, Kwon HY, Zimdahl B, Congdon KL, Blum J, Lento WE, et al. Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature. 2010;466:765\u20138.","journal-title":"Nature"},{"key":"1776_CR39","doi-asserted-by":"publisher","unstructured":"Silkenstedt E, Arenas F, Colom-Sanmart\u00ed B, Xargay-Torrent S, Higashi M, Gir\u00f3 A, et al. Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy. J Exp Clin Cancer Res. 2019;38:446. https:\/\/doi.org\/10.1186\/S13046-019-1458-7.","DOI":"10.1186\/S13046-019-1458-7"},{"key":"1776_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/aol.2019.12.01","volume":"4","author":"C Lee","year":"2020","unstructured":"Lee C, Huang X, Di Liberto M, Martin P, Chen-Kiang S. Targeting CDK4\/6 in mantle cell lymphoma. Ann lymphoma. 2020;4:1\u20131.","journal-title":"Ann lymphoma"},{"key":"1776_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15814-8","volume":"11","author":"DTT Nguyen","year":"2020","unstructured":"Nguyen DTT, Lu Y, Chu KL, Yang X, Park SM, Choo ZN, et al. HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cells. Nat Commun. 2020;11:2026.","journal-title":"Nat Commun"},{"key":"1776_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.leukres.2017.01.015","volume":"54","author":"A Hattori","year":"2017","unstructured":"Hattori A, McSkimming D, Kannan N, Ito T. RNA binding protein MSI2 positively regulates FLT3 expression in myeloid leukemia. Leuk Res. 2017;54:47\u201354.","journal-title":"Leuk Res"},{"key":"1776_CR43","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1172\/JCI78440","volume":"125","author":"SM Park","year":"2015","unstructured":"Park SM, G\u00f6nen M, Vu L, Minuesa G, Tivnan P, Barlowe TS, et al. Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program. J Clin Invest. 2015;125:1286\u201398.","journal-title":"J Clin Invest"},{"key":"1776_CR44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/35075094","volume":"411","author":"M Okabe","year":"2001","unstructured":"Okabe M, Imai T, Kurusu M, Hiromi Y, Okano H. Translational repression determines a neuronal potential in Drosophila asymmetric cell division. Nature. 2001;411:94\u201398.","journal-title":"Nature"},{"key":"1776_CR45","doi-asserted-by":"crossref","unstructured":"Palacios F, Yan XJ, Ferrer G, Chen SS, Vergani S, Yang X, et al. Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target. Leukemia. 2021;35:1037\u201352.","DOI":"10.1038\/s41375-020-01115-y"},{"key":"1776_CR46","doi-asserted-by":"publisher","unstructured":"Vegliante MC, Royo C, Palomero J, Salaverria I, Balint B, Mart\u00edn-Guerrero I, et al. Epigenetic activation of SOX11 in lymphoid neoplasms by histone modifications. PLoS One. 2011;6:e21382. https:\/\/doi.org\/10.1371\/journal.pone.0021382.","DOI":"10.1371\/journal.pone.0021382"},{"key":"1776_CR47","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1089\/ten.tea.2010.0085","volume":"16","author":"BL Larson","year":"2010","unstructured":"Larson BL, Ylostalo J, Lee RH, Gregory C, Prockop DJ. Sox11 is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cells. Tissue Eng Part A. 2010;16:3385\u201394.","journal-title":"Tissue Eng Part A"},{"key":"1776_CR48","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/stem.3192","volume":"38","author":"F Yu","year":"2020","unstructured":"Yu F, Wu F, Li F, Liao X, Wang Y, Li X, et al. Wnt7b-induced Sox11 functions enhance self-renewal and osteogenic commitment of bone marrow mesenchymal stem cells. Stem Cells. 2020;38:1020\u201333.","journal-title":"Stem Cells"},{"key":"1776_CR49","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/j.1460-9568.2009.06768.x","volume":"29","author":"A Haslinger","year":"2009","unstructured":"Haslinger A, Schwarz TJ, Covic M, Chichung Lie D. Expression of Sox11 in adult neurogenic niches suggests a stage-specific role in adult neurogenesis. Eur J Neurosci. 2009;29:2103\u201314.","journal-title":"Eur J Neurosci"},{"key":"1776_CR50","doi-asserted-by":"publisher","first-page":"e34827","DOI":"10.1371\/journal.pone.0034827","volume":"7","author":"EL Wuebben","year":"2012","unstructured":"Wuebben EL, Mallanna SK, Cox JL, Rizzino A. Musashi2 is required for the self-renewal and pluripotency of embryonic stem cells. PLoS One. 2012;7:e34827.","journal-title":"PLoS One"},{"key":"1776_CR51","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nm.2187","volume":"16","author":"MG Kharas","year":"2010","unstructured":"Kharas MG, Lengner CJ, Al-Shahrour F, Bullinger L, Ball B, Zaidi S, et al. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nat Med. 2010;16:903\u20138.","journal-title":"Nat Med"},{"key":"1776_CR52","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1073\/pnas.1513616113","volume":"113","author":"AE Kudinov","year":"2016","unstructured":"Kudinov AE, Deneka A, Nikonova AS, Beck TN, Ahn Y-H, Liu X, et al. Musashi-2 (MSI2) supports TGF-\u03b2 signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis. Proc Natl Acad Sci USA. 2016;113:6955\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1776_CR53","first-page":"1","volume":"6","author":"S Wang","year":"2015","unstructured":"Wang S, Li N, Yousefi M, Nakauka-Ddamba A, Li F, Parada K, et al. Transformation of the intestinal epithelium by the MSI2 RNA-binding protein. Nat Commun. 2015;6:1\u201315.","journal-title":"Nat Commun"},{"key":"1776_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10739","volume":"7","author":"J Taggart","year":"2016","unstructured":"Taggart J, Ho TC, Amin E, Xu H, Barlowe TS, Perez AR, et al. MSI2 is required for maintaining activated myelodysplastic syndrome stem cells. Nat Commun. 2016;7:10739.","journal-title":"Nat Commun"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-022-01776-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-022-01776-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-022-01776-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T20:05:50Z","timestamp":1675541150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-022-01776-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1776"],"URL":"https:\/\/doi.org\/10.1038\/s41375-022-01776-x","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"1 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}